Invention Grant
- Patent Title: Pyrimidinone carboxamide inhibitors of endothelial lipase
- Patent Title (中): 嘧啶酮甲酰胺抑制剂内皮脂肪酶
-
Application No.: US14390152Application Date: 2013-04-01
-
Publication No.: US09394260B2Publication Date: 2016-07-19
- Inventor: Carol Hui Hu , Jennifer X. Qiao , Tammy C. Wang
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Barry H. Jacobsen
- International Application: PCT/US2013/034786 WO 20130401
- International Announcement: WO2013/151923 WO 20131010
- Main IPC: C07D401/12
- IPC: C07D401/12 ; A61K31/513 ; C07D239/557 ; A61K31/5377 ; C07D403/12 ; C07D401/14 ; C07D403/14 ; C07D413/12 ; C07D417/12 ; C07D417/14
Abstract:
The present invention provides compounds of Formula (I): (I) as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used as medicaments.
Public/Granted literature
- US20150361052A1 PYRIMIDINONE CARBOXAMIDE INHIBITORS OF ENDOTHELIAL LIPASE Public/Granted day:2015-12-17
Information query
